SONIA
BURGAZ GARCÍA-OTEYZA
Predoctoral
![Foto de SONIA](/img/nophoto.png)
![Foto de Instituto Ramón y Cajal de Investigación Sanitaria](/img/noimage_org.png)
Instituto Ramón y Cajal de Investigación Sanitaria
Madrid, EspañaInstituto Ramón y Cajal de Investigación Sanitaria -ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2021
-
Bip heterozigosity aggravates pathological deterioration in experimental amyotrophic lateral sclerosis
International Journal of Molecular Sciences, Vol. 22, Núm. 22
-
Neuroprotection with the cannabidiol quinone derivative VCE-004.8 (EHP-101) against 6-hydroxydopamine in cell and murine models of Parkinson’s disease
Molecules, Vol. 26, Núm. 11
-
Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice
Molecular and Cellular Neuroscience, Vol. 110
-
Preclinical investigation in neuroprotective effects of the gpr55 Ligand VCE-006.1 in experimental models of Parkinson’s disease and amyotrophic lateral sclerosis
Molecules, Vol. 26, Núm. 24
2020
-
Beneficial effects of the phytocannabinoid Δ9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease
Neurobiology of Disease, Vol. 141